Engineered cell homing.

One of the greatest challenges in cell therapy is to minimally invasively deliver a large quantity of viable cells to a tissue of interest with high engraftment efficiency. Low and inefficient homing of systemically delivered mesenchymal stem cells (MSCs), for example, is thought to be a major limitation of existing MSC-based therapeutic approaches, caused predominantly by inadequate expression of cell surface adhesion receptors. Using a platform approach that preserves the MSC phenotype and does not require genetic manipulation, we modified the surface of MSCs with a nanometer-scale polymer construct containing sialyl Lewis(x) (sLe(x)) that is found on the surface of leukocytes and mediates cell rolling within inflamed tissue. The sLe(x) engineered MSCs exhibited a robust rolling response on inflamed endothelium in vivo and homed to inflamed tissue with higher efficiency compared with native MSCs. The modular approach described herein offers a simple method to potentially target any cell type to specific tissues via the circulation.

[1]  D. Vestweber,et al.  E‐SELECTIN EXPRESSION IN EXPERIMENTAL MODELS OF INFLAMMATION IN MICE , 1996, The Journal of pathology.

[2]  Richard Tuli,et al.  Adult mesenchymal stem cells and cell-based tissue engineering , 2002, Arthritis research & therapy.

[3]  D. Hammer,et al.  Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. , 2003, Biophysical journal.

[4]  J. Karp,et al.  Mesenchymal stem cell therapy: Two steps forward, one step back. , 2010, Trends in Molecular Medicine.

[5]  Klaus Ley,et al.  Analysis of leukocyte rolling in vivo and in vitro. , 2006, Methods in enzymology.

[6]  D. Hammer,et al.  Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. , 2000, Biophysical journal.

[7]  Z. Popović,et al.  SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Petr Malý,et al.  The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking through an Essential Role in L-, E-, and P-selectin Ligand Biosynthesis , 1996, Cell.

[9]  Robert A. Kloner,et al.  Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.

[10]  S. Simon,et al.  Molecular mechanics and dynamics of leukocyte recruitment during inflammation. , 2005, Annual review of biomedical engineering.

[11]  K E Norman,et al.  Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. , 1995, Blood.

[12]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[13]  David S. Long,et al.  Near-Wall μ-PIV Reveals a Hydrodynamically Relevant Endothelial Surface Layer in Venules In Vivo , 2003 .

[14]  I. Veilleux,et al.  In Vivo Cell Tracking With Video Rate Multimodality Laser Scanning Microscopy , 2008, IEEE Journal of Selected Topics in Quantum Electronics.

[15]  K E Norman,et al.  Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. , 1998, The Journal of clinical investigation.

[16]  Paul Kubes,et al.  The microcirculation and inflammation: modulation of leukocyte‐endothelial cell adhesion , 1994, Journal of leukocyte biology.

[17]  A. Caplan.  Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.

[18]  R. Sackstein.  The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. , 2004, The journal of investigative dermatology. Symposium proceedings.

[19]  I. Bellantuono,et al.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. , 2004, Blood.

[20]  M. Lawrence,et al.  PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow. , 2005, American journal of physiology. Cell physiology.

[21]  Jeffrey M Karp,et al.  Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.

[22]  J. Karp,et al.  Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. , 2010, Biomaterials.

[23]  Charles P. Lin,et al.  Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone , 2008, Nature Medicine.

[24]  U. V. von Andrian,et al.  Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. , 2000, Immunity.

[25]  M. U. Nollert,et al.  P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils , 1995, The Journal of cell biology.

[26]  W. Rombouts,et al.  Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture , 2003, Leukemia.

[27]  Jeffrey M Karp,et al.  Chemical engineering of mesenchymal stem cells to induce a cell rolling response. , 2008, Bioconjugate chemistry.

[28]  A. Pries,et al.  Corrections and Retraction , 2004 .

[29]  J. Neuberger,et al.  Growth of normal human hepatocytes in primary culture: Effect of hormones and growth factors on DNA synthesis , 1991, Hepatology.

[30]  M. Ashraf,et al.  Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. , 2008, Journal of molecular and cellular cardiology.

[31]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[32]  Xunbin Wei,et al.  Imaging Molecular Expression on Vascular Endothelial Cells by In Vivo Immunofluorescence Microscopy , 2006, Molecular imaging.

[33]  L. Ou,et al.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  R. Alon,et al.  Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.

[35]  D. Hammer,et al.  Sialyl LewisX-Mediated, PSGL-1-Independent RollingAdhesion on P-selectin , 2000 .

[36]  S Chien,et al.  In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat. , 1980, Microvascular research.